UNASSIGNED: Objectives: The aim of this study is to report on the treatment of mandibular @entity6876 with @entity26098 ( @entity26098 ) combined with a bTCP/HA (b-tricalcium phosphate/ @entity692 ) alloplastic material. Method and Materials: Thirteen @entity1 were selected. All @entity1 were nonsmokers, systemically healthy, and diagnosed with @entity7278 ; had not taken medications known to interfere with periodontal tissue health and healing; presented one Class II mandibular furcation defect with horizontal probing equal to or greater than 4 mm at buccal site. The clinical parameters evaluated were @entity92 ( @entity92 ), relative @entity2522 (RGMP), relative vertical clinical attachment level (RVCAL), and relative horizontal clinical attachment level (RHCAL). A paired Student t test was used to detect differences between the baseline and 6-month measurements, with the level of significance of .05. Results: After 6 months, the treatment produced a statistically significant reduction in @entity92 and a significant gain in RVCAL and RHCAL, but no observable change in RGMP. RVCAL ranged from 13.77 (   1.31) at baseline to 12.15 (   1.29) after 6 months, with a mean change of -1.62    1.00 mm (P < .05). RHCAL ranged from 5.54 (   0.75) to 2.92 (   0.92), with a mean change of -2.62    0.63 mm (P < .05). After 6 months, 76.92% of the @entity1 improved their diagnosis to @entity6876 while 23.08% remained as Class II. Conclusion: The present study has shown that positive clinical results may be expected from the combined treatment of @entity6876 with @entity26098 and bTCP/HA, especially considering the gain of horizontal attachment level. Despite this result, controlled clinical studies are needed to confirm our outcomes.

Enamel matrix protein derivative plus synthetic bone substitute for the treatment of mandibular XXXX : A case series.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity6876 :: ('MESH:D017823', 'Disease') :: ['Class II furcation defects', 'Class I furcation defects'] @entity7278 :: ('MESH:D055113', 'Disease') :: ['chronic periodontitis'] @entity26098 :: ('MESH:C535501', 'Disease') :: ['EMD', 'enamel matrix protein derivative'] @entity2522 :: ('MESH:D005891', 'Disease') :: ['gingival margin position'] @entity692 :: ('MESH:D017886', 'Chemical') :: ['hydroxyapatite'] @entity92 :: ('MESH:D007222', 'Disease') :: ['PD', 'probing depth']
@entity6876 :: (MESH:D017823,Disease) :: ['Class II furcation defects']
